00882 TIANJIN DEV
- 1.900
- +0.020+1.06%
TIANJIN DEV News
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
TIANJIN DEV: Notification Letter to Non-registered Shareholders and Request Form
TIANJIN DEV: Notification Letter to Existing Shareholders and Request Form
TIANJIN DEV: Form of Proxy for Annual General Meeting to be held on 13 June 2024
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
TIANJIN DEV: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
TIANJIN DEV: List of Directors and their Roles and Functions
TIANJIN DEV: Change of Chairman of the Board, Authorised Representative and Change in Composition of Nomination Committee, Remuneration Committee and Investment Committee
TIANJIN DEV: Final Dividend for the year ended 31 December 2023
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
TIANJIN DEV: Overseas Regulatory Announcement
TIANJIN DEV: Announcement Pursuant to Rule 13.18 of the Listing Rules
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
TIANJIN DEV: Overseas Regulatory Announcement
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
TIANJIN DEV: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
TIANJIN DEV: Reply Form - Election as to Means of Receipt of Corporate Communications
TIANJIN DEV: First Letter - Election as to Means of Receipt of Corporate Communications
TIANJIN DEV: Election of Means of Receipt of Corporate Communications
TIANJIN DEV: Potential Acquisition of 65% Equity Interest in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
